Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II TrialsGerardo Rosati, Roberto Bordonaro, Alfredo Butera et al.|Cancers|2019Cited by 6
Oxaliplatin-based chemotherapy in patients aged at least 75 years with metastatic colorectal cancer: a post-hoc subgroup analysis if three phase II studiesGerardo Rosati, Roberto Bordonaro, Stefano Cordio et al.|Annals of Oncology|2019Cited by 0